Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
233.01
+3.86 (1.68%)
May 13, 2025, 2:45 PM CST
SHE:300760 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 11,137 | 11,668 | 11,582 | 9,607 | 8,002 | 6,658 | Upgrade
|
Depreciation & Amortization | 1,444 | 1,444 | 1,010 | 885.06 | 700.41 | 472.12 | Upgrade
|
Other Amortization | 58.7 | 58.7 | 29.16 | 26.31 | 16.65 | 10.96 | Upgrade
|
Loss (Gain) From Sale of Assets | -4.24 | -4.24 | -2.46 | -6.16 | -4.07 | 2.07 | Upgrade
|
Asset Writedown & Restructuring Costs | 1.75 | 1.75 | 274.92 | 0.74 | 0.62 | 16.87 | Upgrade
|
Loss (Gain) From Sale of Investments | -178.72 | -178.72 | -69.56 | 5.06 | -0.81 | 4.47 | Upgrade
|
Provision & Write-off of Bad Debts | 298.93 | 298.93 | 244.18 | 36.78 | -5.94 | 29.64 | Upgrade
|
Other Operating Activities | -450 | 388.97 | 33.63 | -145.31 | -103.06 | 354.27 | Upgrade
|
Change in Accounts Receivable | -347.15 | -347.15 | -680.91 | -1,047 | -153.44 | -3.27 | Upgrade
|
Change in Inventory | -782.05 | -782.05 | -201.43 | -523.01 | -133.63 | -1,448 | Upgrade
|
Change in Accounts Payable | 402.21 | 402.21 | -769.19 | 3,094 | 615.09 | 2,827 | Upgrade
|
Change in Other Net Operating Assets | -78.85 | -78.85 | 253.87 | 382.89 | 5.4 | - | Upgrade
|
Operating Cash Flow | 11,062 | 12,432 | 11,062 | 12,141 | 8,999 | 8,870 | Upgrade
|
Operating Cash Flow Growth | -12.16% | 12.38% | -8.89% | 34.92% | 1.45% | 87.86% | Upgrade
|
Capital Expenditures | -2,055 | -1,959 | -2,689 | -1,916 | -1,402 | -1,183 | Upgrade
|
Sale of Property, Plant & Equipment | 31.32 | 30.74 | 21.66 | 73.33 | 21.73 | 2.83 | Upgrade
|
Cash Acquisitions | -5,773 | -5,773 | -870.82 | - | -3,520 | - | Upgrade
|
Investment in Securities | 372.54 | 311.87 | 2,689 | -1,558 | - | -4,020 | Upgrade
|
Other Investing Activities | 8.49 | 6.92 | 156.15 | 180.02 | 88.32 | 8.75 | Upgrade
|
Investing Cash Flow | -7,416 | -7,383 | -692.93 | -3,220 | -4,812 | -5,191 | Upgrade
|
Long-Term Debt Issued | - | 15.14 | - | - | - | - | Upgrade
|
Total Debt Issued | 15.2 | 15.14 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -162.94 | -142.46 | -103.35 | -537.94 | - | Upgrade
|
Total Debt Repaid | -160.77 | -162.94 | -142.46 | -103.35 | -537.94 | - | Upgrade
|
Net Debt Issued (Repaid) | -145.57 | -147.79 | -142.46 | -103.35 | -537.94 | - | Upgrade
|
Issuance of Common Stock | - | - | - | 152.43 | - | - | Upgrade
|
Repurchase of Common Stock | -5.4 | -5.4 | -6.08 | -999.94 | -999.99 | - | Upgrade
|
Common Dividends Paid | -8,743 | -8,743 | -10,670 | -4,233 | -3,039 | -1,824 | Upgrade
|
Other Financing Activities | 21.78 | 13.98 | 42.47 | -10.54 | -27.71 | -29.59 | Upgrade
|
Financing Cash Flow | -8,872 | -8,882 | -10,776 | -5,194 | -4,605 | -1,853 | Upgrade
|
Foreign Exchange Rate Adjustments | 94.99 | 72.19 | 101.37 | 113.82 | -171.45 | -197.47 | Upgrade
|
Net Cash Flow | -5,131 | -3,761 | -305.22 | 3,841 | -589.78 | 1,628 | Upgrade
|
Free Cash Flow | 9,007 | 10,473 | 8,373 | 10,226 | 7,596 | 7,687 | Upgrade
|
Free Cash Flow Growth | -10.18% | 25.07% | -18.11% | 34.62% | -1.19% | 94.87% | Upgrade
|
Free Cash Flow Margin | 25.31% | 28.52% | 23.97% | 33.67% | 30.06% | 36.56% | Upgrade
|
Free Cash Flow Per Share | 7.43 | 8.65 | 6.91 | 8.45 | 6.25 | 6.32 | Upgrade
|
Cash Income Tax Paid | 3,293 | 3,293 | 3,100 | 2,712 | 2,069 | 1,605 | Upgrade
|
Levered Free Cash Flow | 5,345 | 6,565 | 3,871 | 7,485 | 4,887 | 5,715 | Upgrade
|
Unlevered Free Cash Flow | 5,358 | 6,577 | 3,879 | 7,492 | 4,893 | 5,715 | Upgrade
|
Change in Net Working Capital | 1,387 | 598.38 | 2,350 | -1,682 | -100.72 | -1,878 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.